Switch to:
More From Other Websites
This is What Happens When A New Drug Hits the Market and Nobody Knows What to Expect Jul 22 2014
[video] Earnings Preview: 3 Things to Watch Jul 22 2014
Gilead Sciences Should Report $4B In Sovaldi Sales In Q2'14 Jul 22 2014
Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A) Jul 22 2014
Alexion, 3 Other Top Biotechs Reporting Earnings Jul 22 2014
Gilead Expected to Post Sky-High Hep C Sales in June Quarter Jul 22 2014
HIV pills show more promise to prevent infection Jul 22 2014
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? Jul 22 2014
Biogen Shares Rebound As Street Has A Change Of Heart Jul 21 2014
[video]Why I'm Shorting Gilead: Sentiment Is Too Positive Ahead of Earnings Jul 21 2014
[video] Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People Jul 21 2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers Jul 21 2014
Gilead Sciences: Sovaldi's a Blockbuster, the Question is How Big Jul 21 2014
Gilead (GILD) Reaches New Lifetime High Today Jul 21 2014
How Will Gilead Sciences (GILD) Stock Be Affected By Solvadi Hepatitis C Finding? Jul 21 2014
[$$] Lucrative Drug Niche Sparks Legal Scramble Jul 21 2014
CVS officials say Sovaldi pricing in line with history, but unsustainable Jul 20 2014
Gilead Drug Combination Cures Hepatitis C in HIV Patients Jul 20 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide